Zacks Investment Research lowered shares of Ageas SA (OTCMKTS:AGESY) from a hold rating to a strong sell rating in a research report sent to investors on Monday morning.

According to Zacks, “Ageas, formerly known as Fortis, is an international insurance company. The Company has chosen to concentrate its business activities in Europe and Asia. Ageas offers international insurance services such as life and non-life, disability, and medical to individuals and groups. The Company also has subsidiaries in France, Germany, Turkey, Ukraine and Hong Kong. Ageas operates partnerships in Luxembourg, Italy, Portugal, China, Malaysia, India and Thailand. “

Shares of Ageas SA (AGESY) traded up $0.25 during midday trading on Monday, hitting $47.76. 1,703 shares of the stock traded hands, compared to its average volume of 3,317. Ageas SA has a 1-year low of $36.98 and a 1-year high of $49.47. The firm has a market capitalization of $9,908.81, a price-to-earnings ratio of 63.95 and a beta of 0.87.

COPYRIGHT VIOLATION WARNING: “Ageas SA (AGESY) Downgraded by Zacks Investment Research to Strong Sell” was first reported by Watch List News and is the property of of Watch List News. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The original version of this news story can be accessed at https://www.watchlistnews.com/ageas-sa-agesy-downgraded-by-zacks-investment-research-to-strong-sell/1703207.html.

About Ageas SA

ageas SA is an international insurance company. The Company’s business segments include Belgium, the United Kingdom, Continental Europe, Asia and General Account. The Belgian insurance activities operate under the name of AG Insurance. The Company’s business in the United Kingdom is a national provider of Nonlife insurance solutions.

Receive News & Ratings for Ageas SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ageas SA and related companies with Analyst Ratings Network's FREE daily email newsletter.